Home » Stocks » Evolus

Evolus, Inc. (EOLS)

Stock Price: $3.44 USD -0.09 (-2.55%)
Updated Oct 22, 2020 4:00 PM EDT - Market closed
After-hours: $3.43 -0.01 (-0.29%) Oct 22, 4:59 PM

Stock Price Chart

Key Info

Market Cap 116.09M
Revenue (ttm) 50.92M
Net Income (ttm) -82.35M
Shares Out 33.75M
EPS (ttm) -2.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 22, 2020
Last Price $3.44
Previous Close $3.53
Change ($) -0.09
Change (%) -2.55%
Day's Open 3.55
Day's Range 3.40 - 3.59
Day's Volume 399,730
52-Week Range 3.00 - 17.68

More Stats

Market Cap 116.09M
Enterprise Value 128.71M
Earnings Date (est) Nov 9, 2020
Ex-Dividend Date n/a
Shares Outstanding 33.75M
Float 21.95M
EPS (basic) -2.63
EPS (diluted) -2.62
FCF / Share -2.57
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.43M
Short Ratio 7.15
Short % of Float 15.62%
Beta 2.73
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.28
PB Ratio 2.73
Revenue 50.92M
Operating Income -73.96M
Net Income -82.35M
Free Cash Flow -86.84M
Net Cash -12.62M
Net Cash / Share -0.37
Gross Margin 52.85%
Operating Margin -145.26%
Profit Margin -161.70%
FCF Margin -170.55%
ROA -25.32%
ROE -194.26%
ROIC -49.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 5
Overweight 0
Hold 2
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$10.62*
(208.72% upside)
Low
4.00
Current: $3.44
High
35.00
Target: 10.62
*Average 12-month price target from 8 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue34.93----
Gross Profit26.91----
Operating Income-98.95-46.14-11.73-19.97-30.98
Net Income-90.03-46.87-4.48-20.07-31.11
Shares Outstanding28.2424.4016.5316.5316.53
Earnings Per Share-3.19-1.92-0.27-1.21-1.88
Operating Cash Flow-93.38-25.67-13.22-13.27-36.38
Capital Expenditures-4.57-0.01---
Free Cash Flow-97.95-25.68-13.22-13.27-36.38
Cash & Equivalents13093.16-0.194.00
Total Debt96.5516.9021159.7646.17
Net Cash / Debt33.2676.26-211-59.57-42.17
Assets24017215277.5081.30
Liabilities16187.4622884.6069.30
Book Value79.4684.38-75.54-7.1112.00
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Evolus, Inc.
Country United States
Employees 127
CEO David Moatazedi

Stock Information

Ticker Symbol EOLS
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: EOLS
IPO Date February 8, 2018

Description

Evolus, a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was founded in 2012 and is headquartered in Newport Beach, California.